GENE ONLINE|News &
OS Therapies Completes $5.25 Million Registered Direct Offering with Support from Existing Investors
OS Therapies has successfully completed a $5.25 million registered direct offering, primarily involving pre-existing high-net-worth investors. The company announced the completion of the funding round on April 2, 2026, highlighting its focus on securing financial backing from its established investor base.
The offering was structured as a registered direct placement, allowing OS Therapies to raise capital directly from investors without intermediaries. According to the company, the majority of participants in this funding round were individuals or entities that had previously invested in OS Therapies. Further details regarding the specific terms of the offering or how the funds will be allocated were not disclosed at this time.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 2, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
Fire Incident Reported at Crushing Circuit of B2Gold’s Goose Mine Project on April 18, 2026
2026-04-18
Study in BMC Geriatrics Examines Differing Views of Healthcare Professionals and Families on Deprescribing Preventive Medications for Dementia Patients
2026-04-18
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
